Justin Chan serves as Director of Viral Hepatitis Services for NYC Health + Hospitals / Correctional Health Services, working to expand HCV care in NYC jails. He received his MD from Icahn School of Medicine at Mount Sinai, and his MPH from the Harvard T.H. Chan School of Public Health.

Dr Lafferty is a research fellow at the Centre for Social Research in Health, UNSW Sydney. Her research focuses on the social and behavioural components underpinning hepatitis C risk, prevention, transmission, testing, treatment, and reinfection in the prison setting.

Sophia is a PhD candidate and works at Burnet Institute across multiple projects. She has a particular interest in qualitative research seeking to understand and address barriers to wellbeing among marginalised and key populations; including people who use drugs, prisoners, gay and bisexual men, and young people.

Matthew Akiyama is a physician-investigator whose research focuses on HCV among socioeconomically marginalized populations and the criminal justice system. Dr. Akiyama is the recipient of NIH and institutional funding to develop and test innovative strategies to improve the HCV care cascade among individuals with justice-involvement and people who inject drugs.

Trained in economics, I currently work on the modelling of hepatitis C among priority populations (people who inject drugs, people in prison) and the impact of prison-based interventions in a microelimination framework.

Dr. Nadine Kronfli is an assistant professor in the Department of Medicine, Division of Infectious Diseases at McGill University and a Junior Scientist at the Research Institute of the McGill University Health Centre. Her research focuses on improving engagement in hepatitis C care for people in prison.